1. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review

   • Angela Lisibach
   • Valérie Benelli
   • Monika Lutters

   Review Open access 03 October 2020 Pages: 147 - 162

   

2. Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride

   • Stefanie Fekete
   • K. Egberts
   • M. Gerlach

   Clinical Trial Open access 28 September 2020 Pages: 163 - 170

   

3. Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

   • Alexandra Jobert
   • Edouard-Jules Laforgue
   • Caroline Victorri-Vigneau

   Clinical Trial 02 October 2020 Pages: 171 - 177

   

4. A real or apparent decrease in glomerular filtration rate in patients using olaparib?

   • M. A. C. Bruin
   • C. M. Korse
   • A. D. R. Huitema

   Pharmacodynamics Open access 14 December 2020 Pages: 179 - 188

   

5. Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h

   • Justine Touchard
   • G. Perrin
   • B. Sabatier

   Pharmacoeconomics 14 September 2020 Pages: 189 - 195

   

6. Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults

   • Brianna Kispal
   • Sandra A. N. Walker

   Pharmacokinetics and Disposition 25 September 2020 Pages: 197 - 205

   

7. Ceftriaxone dosing in patients admitted from the emergency department with sepsis

   • Aaron J. Heffernan
   • Rebecca A. Curran
   • Jeffrey Lipman

   Pharmacokinetics and Disposition 24 September 2020 Pages: 207 - 214

   

8. Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients

   • Marit Tveito
   • Robert Løvsletten Smith
   • Gudrun Høiseth

   Pharmacokinetics and Disposition 30 September 2020 Pages: 215 - 221

   

9. Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects

   • Allison Gaudy
   • Christian Atsriku
   • Maria Palmisano

   Pharmacokinetics and Disposition 23 September 2020 Pages: 223 - 231

   

10. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

    • Milo Gatti
    • Emanuel Raschi
    • Fabrizio De Ponti

    Pharmacoepidemiology and Prescription Open access 08 September 2020 Pages: 233 - 239

    

11. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia

    • Damiana Scuteri
    • Marilù Vulnera
    • Maria Tiziana Corasaniti

    Pharmacoepidemiology and Prescription Open access 15 September 2020 Pages: 241 - 249

    

12. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics

    • Abdullah Albassam
    • Dyfrig A. Hughes

    Pharmacoepidemiology and Prescription Open access 29 September 2020 Pages: 251 - 260

    

13. Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19

    • Qibo Fu
    • Xiao Zheng
    • Shaoqing Ni

    Letter to the Editor 01 September 2020 Pages: 261 - 263

14. Iron chelation may harm patients with COVID-19

    • Michael D. Garrick
    • Andrew J. Ghio

    Letter to the Editor 01 September 2020 Pages: 265 - 266

15. Reply: Iron chelation may harm patients with COVID-19

    • Anis Abobaker

    Letter to the Editor 01 September 2020 Pages: 267 - 268

16. Triptan overuse during pregnancy: a possible cause of placental hypoperfusion

    • Delphine Viard
    • Alexandre Gérard
    • Milou-Daniel Drici

    Letter to the Editor 04 September 2020 Pages: 269 - 270

17. Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology

    • Ozan E. Eren
    • Florian Schöberl
    • Andreas Straube

    Letter to the Editor Open access 16 September 2020 Pages: 271 - 272

18. Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience

    • Mihika B. Dave
    • Alpa J. Dherai
    • Tester F. Ashavaid

    Correction 04 September 2020 Pages: 273 - 274